60 related articles for article (PubMed ID: 20964447)
1. HEHEHE-tagged affibody molecule may be purified by IMAC, is conveniently labeled with [⁹⁹(m)Tc(CO)₃](+), and shows improved biodistribution with reduced hepatic radioactivity accumulation.
Tolmachev V; Hofström C; Malmberg J; Ahlgren S; Hosseinimehr SJ; Sandström M; Abrahmsén L; Orlova A; Gräslund T
Bioconjug Chem; 2010 Nov; 21(11):2013-22. PubMed ID: 20964447
[TBL] [Abstract][Full Text] [Related]
2. Preparation, Characterization, and Radiolabeling of Anti-HER2 scFv With Technetium Tricarbonyl and Stability Studies.
Bozorgchami N; Ahmadzadeh M; Hatamabadi D; Yazdani A; Shahhosseini S; Mohit E
J Labelled Comp Radiopharm; 2024 May; 67(5):168-179. PubMed ID: 38485465
[TBL] [Abstract][Full Text] [Related]
3. Comparison of approaches for increasing affinity of affibody molecules for imaging of B7-H3: dimerization and affinity maturation.
Oroujeni M; Carlqvist M; Ryer E; Orlova A; Tolmachev V; Frejd FY
EJNMMI Radiopharm Chem; 2024 Apr; 9(1):30. PubMed ID: 38625607
[TBL] [Abstract][Full Text] [Related]
4. Expression and Purification of His-Tagged Variants of Human Hepatitis A Virus 3C Protease.
Karaseva MA; Gramma VA; Safina DR; Lunina NA; Komissarov AA; Kostrov SV; Demidyuk IV
Protein Pept Lett; 2024 Apr; ():. PubMed ID: 38644721
[TBL] [Abstract][Full Text] [Related]
5. IMAC capture of recombinant protein from unclarified mammalian cell feed streams.
Kinna A; Tolner B; Rota EM; Titchener-Hooker N; Nesbeth D; Chester K
Biotechnol Bioeng; 2016 Jan; 113(1):130-40. PubMed ID: 26174988
[TBL] [Abstract][Full Text] [Related]
6. Direct In Vivo Comparison of
Tolmachev V; Bodenko V; Oroujeni M; Deyev S; Konovalova E; Schulga A; Lindbo S; Hober S; Bragina O; Orlova A; Vorobyeva A
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499504
[TBL] [Abstract][Full Text] [Related]
7. Comparative Preclinical Evaluation of Peptide-Based Chelators for the Labeling of DARPin G3 with
Larkina M; Plotnikov E; Bezverkhniaia E; Shabanova Y; Tretyakova M; Yuldasheva F; Zelchan R; Schulga A; Konovalova E; Vorobyeva A; Garousi J; Gräslund T; Belousov M; Tolmachev V; Deyev S
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362226
[TBL] [Abstract][Full Text] [Related]
8. The production of the first functional antibody mimetic in higher plants: the chloroplast makes the DARPin G3 for HER2 imaging in oncology.
Ehsasatvatan M; Kohnehrouz BB; Gholizadeh A; Ofoghi H; Shanehbandi D
Biol Res; 2022 Oct; 55(1):32. PubMed ID: 36274167
[TBL] [Abstract][Full Text] [Related]
9. Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules.
Rinne SS; Yin W; Borras AM; Abouzayed A; Leitao CD; Vorobyeva A; Löfblom J; Ståhl S; Orlova A; Gräslund T
Biomedicines; 2022 May; 10(6):. PubMed ID: 35740315
[TBL] [Abstract][Full Text] [Related]
10. Targeting HER2-positive gastric cancer with a novel
Pan Y; Yang Z; Xu Y; Bai Z; Pan D; Yang R; Wang L; Guan W; Yang M
RSC Adv; 2019 Apr; 9(19):10990-10998. PubMed ID: 35515328
[TBL] [Abstract][Full Text] [Related]
11. Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2.
Xu T; Zhang J; Oroujeni M; Tretyakova MS; Bodenko V; Belousov MV; Orlova A; Tolmachev V; Vorobyeva A; Gräslund T
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335898
[TBL] [Abstract][Full Text] [Related]
12. Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody
Liu Y; Vorobyeva A; Xu T; Orlova A; Loftenius A; Bengtsson T; Jonasson P; Tolmachev V; Frejd FY
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34200197
[TBL] [Abstract][Full Text] [Related]
13. Optimal His-Tag Design for Efficient [
Williams JD; Kampmeier F; Badar A; Howland K; Cooper MS; Mullen GED; Blower PJ
Bioconjug Chem; 2021 Jul; 32(7):1242-1254. PubMed ID: 33241692
[TBL] [Abstract][Full Text] [Related]
14. Increasing thermal stability and improving biodistribution of VEGFR2-binding affibody molecules by a combination of in silico and directed evolution approaches.
Güler R; Svedmark SF; Abouzayed A; Orlova A; Löfblom J
Sci Rep; 2020 Oct; 10(1):18148. PubMed ID: 33097752
[TBL] [Abstract][Full Text] [Related]
15. Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond.
Garousi J; Orlova A; Frejd FY; Tolmachev V
EJNMMI Radiopharm Chem; 2020 Jun; 5(1):16. PubMed ID: 32577943
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic Properties of
Larenkov A; Rakhimov M; Lunyova K; Klementyeva O; Maruk A; Machulkin A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32545327
[TBL] [Abstract][Full Text] [Related]
17. Optimal composition and position of histidine-containing tags improves biodistribution of
Vorobyeva A; Schulga A; Konovalova E; Güler R; Löfblom J; Sandström M; Garousi J; Chernov V; Bragina O; Orlova A; Tolmachev V; Deyev SM
Sci Rep; 2019 Jun; 9(1):9405. PubMed ID: 31253840
[TBL] [Abstract][Full Text] [Related]
18. Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of
Dahlsson Leitao C; Rinne SS; Mitran B; Vorobyeva A; Andersson KG; Tolmachev V; Ståhl S; Löfblom J; Orlova A
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30832342
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of
Yang Y; Zhao X; Xing Y; Yu T; Zhang J; Wang J
Oncol Lett; 2018 Oct; 16(4):5361-5366. PubMed ID: 30250607
[TBL] [Abstract][Full Text] [Related]
20. Site-Specific Labeling of F-18 Proteins Using a Supplemented Cell-Free Protein Synthesis System and O-2-[
Yanai A; Harada R; Iwata R; Yoshikawa T; Ishikawa Y; Furumoto S; Ishida T; Yanai K
Mol Imaging Biol; 2019 Jun; 21(3):529-537. PubMed ID: 30112727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
